Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients.

Nyangwara, Vincent Aketch; Mazhindu, Tinashe; Chikwambi, Zedias; Masimirembwa, Collen; Campbell, Thomas B; Borok, Margaret; Ndlovu, Ntokozo

Nyangwara, Vincent Aketch; Mazhindu, Tinashe; Chikwambi, Zedias; Masimirembwa, Collen; Campbell, Thomas B; Borok, Margaret; Ndlovu, Ntokozo.

Afiliação

Nyangwara VA; African Institute of Biomedical Science and Technology, Harare, Zimbabwe.
Mazhindu T; Department of Biotechnology, Chinhoyi University of Technology, Chinhoyi, Zimbabwe.
Chikwambi Z; African Institute of Biomedical Science and Technology, Harare, Zimbabwe.
Masimirembwa C; Unit of Internal Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Campbell TB; African Institute of Biomedical Science and Technology, Harare, Zimbabwe.
Borok M; Department of Biotechnology, Chinhoyi University of Technology, Chinhoyi, Zimbabwe.
Ndlovu N; African Institute of Biomedical Science and Technology, Harare, Zimbabwe.

Br J Clin Pharmacol ; 2023 Jan 11.

Article em En | MEDLINE | ID: mdl-36630266

Palavras-chave

Africa; Zimbabwe; anthracyclines; cardiovascular health; genetics; polymorphisms; risk monitoring

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Zimbábue País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google